Prescription Drug Price Reform of Historic Proportions

Those who refer to the Inflation Reduction Act passed by the Senate this past weekend as “historic” are not exaggerating. The Act represents the most muscular legislation to date to try to tame rising prescription drug prices, which can be devastating for seniors.

Manchin Pulls the Football Away from Schumer – and Medicare

Senator Joe Manchin has once again pulled the proverbial football away from Chuck Schumer just before the kick. After negotiating with the Senate Majority Leader over a pared-back version of the Build Back Better bill, Sen. Manchin has once again withdrawn his support - not for the entire plan, but for key components that would have helped seniors. He declared on Thursday that he would not support any new tax provisions.  One of these provisions would have closed a loophole, compelling the wealthy to pay a 3.8% investment tax.  The revenue would have been directed to the Medicare Part A trust fund, which is currently projected to run dry in 2028. 
2022-07-16T00:42:30-04:00July 15th, 2022|Categories: Congress, Democrats, Medicare, Prescription Drug Prices, Senate, Senator Joe Manchin|

Schumer-Manchin Negotiations May Yield Some Wins for Seniors

The negotiations between Senate Majority Leader Chuck Schumer and Senator Joe Manchin (D-WV) over a new budget reconciliation deal have been great fodder for political journalists, but they are also incredibly important to American seniors.  Senators Schumer and Manchin are haggling over a pared-down version of the Build Back Better legislation, which the West Virginia Senator effectively killed earlier this year, designed to pass with only Democratic votes via the reconciliation process. The new package reportedly retains some crucial items for older Americans:  prescription drug pricing reform and Medicare solvency.
2022-07-13T15:52:53-04:00July 13th, 2022|Categories: Congress, Democrats, Medicare, Prescription Drug Prices, Senate, Senator Joe Manchin|

The Part D Prescription Drug Bait and Switch

Medicare Part D prescription drug beneficiaries can be in for a rude surprise after they sign up for coverage.   In an article this week in Kaiser Health News, Susan Jaffe writes that the price of a drug may jump within a month of a patient enrolling in the Part D drug plan

Aging, Health & Care: A New Resource for Seniors and Their Families

Classic movie star Mae West famously said, “Getting old isn't for the faint of heart.” Most older people probably know what she means. Of course, aging can also be a rewarding time of pursuing hobbies and interests, travel and discovery, and enjoying grandchildren, among other things. But the "not for the faint of heart" part rings particularly true when it comes to participating in our senior health care system

What Does the President’s Budget Mean for Seniors?

There’s encouraging news for seniors in President Biden’s FY2023 budget, even though it does not contain everything that advocates for older Americans had hoped.  The budget, which now will be submitted to Congress, includes crucial funding for services that seniors rely upon – from the operation of the Social Security Administration (SSA) to nutrition programs under the Older Americans Act.

Pending Aduhelm Coverage Decision Could Pave the Way for Lower Medicare Premiums

Medicare Part B beneficiaries have seen their monthly premiums jump to from $148.50 to $170.10 this year – one of the biggest increases in recent history. Many seniors on fixed incomes who welcomed this year’s 5.9% Social Security COLA were dismayed to find that $21 of it will be consumed by the Medicare premium bump.  But this week brought some potentially encouraging news. 
2022-03-21T12:31:59-04:00January 11th, 2022|Categories: COLAs, Congress, Medicare, Medicare premiums, Prescription Drug Prices, President Biden|
Go to Top